Orellanine: From Fungal Origin to a Potential Future Cancer Treatment

Area of Science:

• Natural Products Chemistry
• Medicinal Chemistry
• Toxicology

Background:

• Fungal metabolites are an untapped source for novel anticancer drug development.
• Orellanine, a nephrotoxin from Cortinarius orellanus mushrooms, has historical significance and unique toxicological properties.
• Understanding orellanine's selective toxicity to kidney proximal tubular cells is crucial but remains debated.

Purpose of the Study:

• To review the historical, structural, and toxicological aspects of orellanine.
• To discuss analytical, synthetic, and chemotherapeutic potentials of orellanine.
• To explore challenges and future directions for orellanine's therapeutic optimization.

Main Methods:

• Literature review focusing on orellanine's properties and research.
• Analysis of proposed toxicmechanisms and their relation to molecular structure.
• Examination of synthesis, chromatography, and biological evaluation challenges.

Main Results:

• Orellanine exhibits selective toxicity to proximal tubular cells, with disputed mechanisms.
• Chromatographic analysis and biological evaluation are complicated by metabolites.
• Preclinical studies show promise for metastatic clear cell renal cell carcinoma.

Conclusions:

• Orellanine's therapeutic optimization is limited by analytical and toxicological uncertainties.
• Despite challenges, orellanine's anticancer potential is significant.
• Phase I/II human trials for metastatic renal cell carcinoma are underway, highlighting its therapeutic promise.